From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: making Bara Brith, death threat for the Lemming & I really warm to buying high yield insurers and banks

By Tom Winnifrith | Saturday 17 February 2024


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I start with the Bara Brith, explaining what it is that Joshua and I have made and why. Photos tomorrow. Then it is onto insurers lie Legal & General (LGEN) as well as banks like NatWest (NWG) and, citing a real expert, I explain why I am increasingly tempted. Then it is onto the death threat for the Lemming Investor. It is to do with Skinbiotherapeutics (SBTX) and the perp is almost certainly one of those emboldened by Giles Balleny at Cavendish (CAV) who should now be truly ashamed for that. It makes me consider what Britain is becoming and how, if my circumstances were different, I'd be emigrating and will encourage all my kids to do just that. 
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 18:12:24